Seattle infertility center introduces new technology to patients to minimize risk of hundreds of genetic diseases in their children

Share Article

Pacific NW Fertility first in the United States to offer innovative genetic testing prior to making embryos utilizing donor eggs. Diseases hidden in the combined DNA of sperm and eggs can be revealed before fertilization takes place in the IVF process.

This option for parents is unprecedented and we are very excited to be one of the first clinics to offer this to our patients

Pacific NW Fertility announced today that their center will be the first in the United States to introduce a new technology provided by GenePeeks, a genetic information company. GenePeeks’ new technology, featured last October and July 5, 2015 on CBS’ 60 Minutes, offers parents an innovative option for genetic testing to reduce the risk of hundreds of heritable conditions in their children.

GenePeeks’ service at Pacific NW Fertility analyzes a patient’s DNA, in combination with the DNA of prospective egg donors, screening each client/donor combination for hundreds of inherited genetic disorders and diseases. The process uncovers disease risk hidden inside DNA before conception.

A personalized catalogue of donors, specifically screened for the patient’s unique genetic profile, assists patients in egg donor selection. GenePeeks also provides patients seeking donor sperm a catalogue of risk-screened donor matches.

“This option for parents is unprecedented and we are very excited to be one of the first clinics to offer this to our patients,” Dr. Lorna Marshall of PNWF, says. “All parents want to minimize the chance of their baby having a recessive genetic disorder and this technology maximizes the help we can provide them.”

PNWF, home to one of the country’s most successful donor egg programs, is a national leader utilizing frozen donor eggs. Their patients have had over 200 live births using frozen eggs. Utilizing GenePeeks new tools, PNWF’s donors are all genetically screened before being matched with patients.

“We’ve tested our egg donors for recessive genetic diseases for many years but GenePeeks takes testing to a whole new level,” Stephanie Frickleton, the donor egg program director at PNWF, says. “Now we can use GenePeeks' technology to help our patients make the best choice, the healthiest choice possible when they select an egg donor.”

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jonathan Kipp
since: 05/2011
Follow >
Pacific NW Fertility and IVF Specialists
since: 05/2011
Like >
Visit website